Nobel Laureate Celebrates With Thomson Reuters, Drs. Clotet and Gatell Ten Years of HIV Updates
Posted on: Tuesday, 21 April 2009, 15:13 CDT
Dr.
Professor
During the event, professor Barre-Sinoussi will take questions on the current and future state of HIV research -- including the possibility of obtaining a vaccine, on current available drugs and future therapy options. After questions from attendees and press, she will deliver a keynote speech on HIV pathogenesis and prospects for an HIV/AIDS vaccine.
This event is open to the press, but seating is limited. Please RSVP to
For more information, please visit www.ttmed.com/sida.
About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in
SOURCE Thomson Reuters
Source: PR Newswire
Related Articles
- Stigmatized Indian woman with HIV aborts own baby
- US FDA, Barr to discuss looser Plan B sales
- FDA, Barr to discuss looser Plan B sales
- FDA, Barr to meet on "morning-after pill" status
- Haas, Barr share first round lead at US Senior Open
- Indian man sued after hiding HIV status from wife
- Herpes in pregnancy may raise HIV risk for baby
- Home HIV test could spur early treatment -panel
- HIV Program Shows Promise for Low-Income Teens
- Medicine prize launches Nobel season next week
User Comments (0)

RSS Feeds